Pulmonary hypertension in the developing world: Local registries, challenges, and ways to move forward

Pulmonary hypertension (PH) is a disease that can only be appropriately managed in the ‘rich’ developed countries, as both diagnostic and therapeutic interventions are extremely expensive and expectations for these to be adopted by the developing, economically-challenged countries are neither practi...

Full description

Saved in:
Bibliographic Details
Published in:Global Cardiology Science & Practice 2020-04, Vol.2020 (1), p.e202014-e202014
Main Authors: Idrees, Majdy, Butrous, Ghazwan, Mocunbi, Ana, Sastry, Bhagavathula, Ibrahim, Ahmed, Alobaidallah, Khalid, Hassan, Ahmed, Farghaly, Ayman AH, Yacoub, Magdi
Format: Article
Language:English
Subjects:
Viewpoint
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pulmonary hypertension (PH) is a disease that can only be appropriately managed in the ‘rich’ developed countries, as both diagnostic and therapeutic interventions are extremely expensive and expectations for these to be adopted by the developing, economically-challenged countries are neither practical nor realistic. Furthermore, most of the enormous advances in understanding the pathobiology of PH and the subsequent evidence-based diagnostic and complex treatment algorithms came from the developed world.
ISSN:2305-7823
2305-7823
DOI:10.21542/gcsp.2020.14